HEALTH ECONOMIC OUTCOME ANALYSIS OF STEM CELL MOBILIZATION WITH GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) PLUS PLERIXAFOR VERSUS G-CSF ALONE IN PREPARATION FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH NON-HODGKIN'S LYMPHOMAS (NHL)

被引：0
|
作者：
Pusic, I [1 ]
Kymes, S. M. [2 ]
Lambert, D. L. [2 ]
Gregory, M. [2 ]
DiPersio, J. F. [1 ]
机构：
[1] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA
[2] Washington Univ, Sch Med, Ophthalmol & Visual Sci, St Louis, MO USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.177
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
145
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [1] The use of granulocyte colony stimulating factoR (G-CSF) (filgrastim) alone in the mobilization of stem cell in the autologous stem cell transplantation
    Talhi, S.
    Osmani, S.
    Brahimi, M.
    Yafour, N.
    Bouhass, R.
    Arabi, A.
    Bekadja, M. A.
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (01) : 97 - 99
  • [2] Chemotherapy with granulocyte colony stimulating factor (G-CSF) alone versus granulocyte colony stimulating factor (G-CSF) plus granulocyte-macrophage stimulating factor (GM-CSF) for hematopoietic progenitor cell mobilization in patients with relapsed non-hodgkin's lymphomas (NHLs).
    Hosing, Chitra
    Munsell, Mark
    Popat, Uday
    Korbling, Martin
    Valverde, Rosamar
    Maadani, Farzareh
    Kebriaei, Partow
    Alousi, Amin
    DeLima, Marcos
    McMannis, John
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar H.
    Anderlini, Paolo
    Giralt, Sergio
    Champlin, Richard
    Khouri, Issa
    BLOOD, 2007, 110 (11) : 564A - 564A
  • [3] The use of granulocyte colony stimulating factor (G-CSF) (filgrastim) alone in the mobilization of stem cells in autologous stem cell transplantation
    Osmani, S.
    Talhi, S.
    Brahimi, M.
    Yafour, N.
    Attaf, F.
    Bouhass, R.
    Arabi, A.
    Bekadja, M. -A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S182 - S182
  • [4] Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Nazha, Aziz
    Cook, Rachel
    Vogl, Dan T.
    Mangan, Patricia A.
    Hummel, Kimberly
    Cunningham, Kathleen
    Luger, Selina
    Porter, David
    Schuster, Stephen J.
    O'Doherty, Una
    Sell, Mary
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 844 - 844
  • [5] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    Sung, A. D.
    Grima, D. T.
    Bernard, L. M.
    Brown, S.
    Carrum, G.
    Holmberg, L.
    Horwitz, M. E.
    Liesveld, J. L.
    Kanda, J.
    McClune, B.
    Shaughnessy, P.
    Tricot, G. J.
    Chao, N. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1444 - 1449
  • [6] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    A D Sung
    D T Grima
    L M Bernard
    S Brown
    G Carrum
    L Holmberg
    M E Horwitz
    J L Liesveld
    J Kanda
    B McClune
    P Shaughnessy
    G J Tricot
    N J Chao
    Bone Marrow Transplantation, 2013, 48 : 1444 - 1449
  • [7] Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor
    Teipel, Raphael
    Oelschlaegel, Uta
    Wetzko, Katrin
    Schmiedgen, Maria
    Kramer, Michael
    Ruecker-Braun, Elke
    Hoelig, Kristina
    von Bonin, Malte
    Heidrich, Katharina
    Fuchs, Anke
    Ordemann, Rainer
    Kroschinsky, Frank
    Bornhaeuser, Martin
    Huetter, Gero
    Schmidt, Helmuth
    Ehninger, Gerhard
    Schetelig, Johannes
    Heidenreich, Falk
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2171 - 2177
  • [8] Stem Cell Mobilization With Plerixafor plus G-CSF In Comparison To Cyclophosphamide plus G-CSF and Time-To-Progression After Autologous Stem Cell Transplantation For Multiple Myeloma
    Garfall, Alfred L.
    Dougherty, Andrew
    Vogl, Dan T.
    Weiss, Brendan M.
    Cohen, Adam D.
    Porter, David L.
    O'Doherty, Una
    Mangan, Patricia
    Cunningham, Kathleen
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2013, 122 (21)
  • [9] Value of granulocyte colony stimulating factor (G-CSF) prophylaxis in non-Hodgkin's lymphomas (NHL) treated with CAVPE
    Pappalardo, C
    Corrado, C
    Pan, M
    Dignani, C
    Etchichury, V
    Giannone, C
    Pavlovsky, S
    BLOOD, 1997, 90 (10) : 853 - 853
  • [10] G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis
    Antar, Ahmad
    Otrock, Zaher
    Kharfan-Dabaja, Mohamed
    Abou Ghaddara, Hussein
    Kreidieh, Nabila
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
12345